Irinotecan plus carboplatin versus etoposide plus carboplatin in extensive disease small cell lung cancer: A randomized phase II trial

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7046-7046 ◽  
Author(s):  
A. Schmittel ◽  
L. Fischer von Weikersthal ◽  
M. Sebastian ◽  
H. Link ◽  
K. Schulze ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Extensive Disease ◽  
Randomized Phase Ii

scholarly journals Randomized Phase II Trial of Sequential Chemotherapy in Advanced Non-Small Cell Lung Cancer (SWOG 9806)

2004 ◽  
Vol 10 (15) ◽  
pp. 5022-5026 ◽  
Author(s):  
Martin J. Edelman ◽  
Joseph I. Clark ◽  
Kari Chansky ◽  
Kathy Albain ◽  
Nirmala Bhoopalam ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Sequential Chemotherapy ◽  
Randomized Phase Ii

A Randomized Phase II Trial Using Two Different Treatment Schedules of Gemcitabine and Carboplatin in Patients with Advanced Non???Small-Cell Lung Cancer

2006 ◽  
Vol 1 (1) ◽  
pp. 19-24 ◽  
Author(s):  
Gregory A. Masters ◽  
Athanassios E. Argiris ◽  
Elizabeth A. Hahn ◽  
J Thaddeus Beck ◽  
P Gregory Rausch ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Randomized Phase Ii

scholarly journals P1-215: Three drug regiment (Irinotecan, Carboplatin and Etoposide) as a front line treatment in extensive disease small-cell lung cancer: phase II trial

2007 ◽  
Vol 2 (8) ◽  
pp. S824
Author(s):  
Andriani G. Charpidou ◽  
Nikolaos Katirtzoglou ◽  
Ioannis Gkiozos ◽  
Eleni Karapanagiotou ◽  
Anna Rigopoulou ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Line Treatment ◽  
Front Line ◽  
Small Cell Lung ◽  
Extensive Disease
Sign in / Sign up

Export Citation Format

Share Document